Mackenzie Financial Corp Amneal Pharmaceuticals, Inc. Transaction History
Mackenzie Financial Corp
- $71.6 Billion
- Q2 2025
A detailed history of Mackenzie Financial Corp transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 186,608 shares of AMRX stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186,608
Previous 168,830
10.53%
Holding current value
$1.91 Million
Previous $1.41 Million
6.72%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AMRX
# of Institutions
252Shares Held
146MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$180 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$126 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$120 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$116 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$57.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.55B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...